Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management
暂无分享,去创建一个
L. Vitetta | P. S. Davies | F. Steyn | B. Gray | P. Davies
[1] Y. Probst,et al. Short-term effects of fish and fish oil consumption on total and high molecular weight adiponectin levels in overweight and obese adults. , 2013, Metabolism: clinical and experimental.
[2] M. Krebs,et al. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. , 2012, The American journal of clinical nutrition.
[3] E. Ntzani,et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. , 2012, JAMA.
[4] M. Quon,et al. Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia. , 2012, Atherosclerosis.
[5] K. Morino,et al. Effects of a fish-based diet on the serum adiponectin concentration in young, non-obese, healthy Japanese subjects. , 2010, Journal of atherosclerosis and thrombosis.
[6] S. Evans,et al. Dietary n-3:n-6 fatty acid ratios differentially influence hormonal signature in a rodent model of metabolic syndrome relative to healthy controls , 2010, Nutrition & metabolism.
[7] G. Siest,et al. Expression of inflammatory molecules and associations with BMI in children , 2010, European journal of clinical investigation.
[8] K. Sworczak,et al. Adipose tissue activity in relation to overweight or obesity. , 2010, Endokrynologia Polska.
[9] S. Devkota,et al. A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats , 2010, Nutrition & metabolism.
[10] M. Garg,et al. Plasma n-3 Polyunsaturated Fatty Acids are negatively associated with obesity. , 2009, The British journal of nutrition.
[11] Barbara Bloom,et al. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. , 2009, National health statistics reports.
[12] A. Geelen,et al. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals , 2009, European Journal of Clinical Nutrition.
[13] D. Hougaard,et al. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects. , 2009, Metabolism: clinical and experimental.
[14] P. Reiss,et al. Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss , 2009, PloS one.
[15] Å. Vårtun,et al. Coronary heart disease, serum lipids, platelets and dietary fish in two communities in northern Norway. , 2009, Acta medica Scandinavica.
[16] S. Nomura,et al. Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes. , 2009, Journal of atherosclerosis and thrombosis.
[17] D. Mozaffarian,et al. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. , 2008, Clinical chemistry.
[18] T. Funahashi,et al. Prognostic value of adiponectin for cardiovascular disease and mortality. , 2008, The Journal of clinical endocrinology and metabolism.
[19] B. Person,et al. Nutritional Deficiencies in Morbidly Obese Patients: A New Form of Malnutrition? , 2008, Obesity surgery.
[20] W. Harris,et al. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. , 2008, Atherosclerosis.
[21] A. Farmer,et al. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. , 2008, The Cochrane database of systematic reviews.
[22] O. Receveur,et al. Could the Quality of Dietary Fat, and Not Just Its Quantity, Be Related to Risk of Obesity? , 2008, Obesity.
[23] Min-Seon Kim,et al. Essential Role of Mitochondrial Function in Adiponectin Synthesis in Adipocytes , 2007, Diabetes.
[24] Y. Kamei,et al. Increased Adiponectin Secretion by Highly Purified Eicosapentaenoic Acid in Rodent Models of Obesity and Human Obese Subjects , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[25] J. Tune,et al. Adipokines and Coronary Vasomotor Dysfunction , 2007, Experimental biology and medicine.
[26] J. Schölmerich,et al. High‐fat Diets: Modeling the Metabolic Disorders of Human Obesity in Rodents , 2007, Obesity.
[27] C. Herder,et al. Relationship between adipocyte size and adipokine expression and secretion. , 2007, The Journal of clinical endocrinology and metabolism.
[28] A. Martí,et al. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-α , 2007, British Journal of Nutrition.
[29] G. Lip,et al. Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction. , 2007, International journal of cardiology.
[30] Dariush Mozaffarian,et al. Fish intake, contaminants, and human health: evaluating the risks and the benefits. , 2006, JAMA.
[31] Vineet Chopra,et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. , 2006, European heart journal.
[32] J. Danesh,et al. Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis , 2006, Circulation.
[33] Kohjiro Ueki,et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.
[34] E. Ravussin,et al. Role of adiponectin in human skeletal muscle bioenergetics. , 2006, Cell metabolism.
[35] A. Bartke,et al. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[36] M. Gillum,et al. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. , 2006, Diabetes.
[37] Young-sil Yoon,et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice , 2006, Diabetologia.
[38] M. Hosseinzadeh‐Attar,et al. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet , 2006, Diabetologia.
[39] S. Heymsfield,et al. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. , 2005, The Journal of clinical investigation.
[40] G. Slama,et al. Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[41] Ildikó Kriszbacher,et al. Inflammation, atherosclerosis, and coronary artery disease. , 2005, New England Journal of Medicine.
[42] J. Karbowska,et al. Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPAR gamma. , 2005, Biochemical pharmacology.
[43] A. Martí,et al. Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: role of glucose metabolism. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[44] Adam Drewnowski,et al. Changing the energy density of the diet as a strategy for weight management. , 2005, Journal of the American Dietetic Association.
[45] J. Shaw,et al. Effect of fish diets and weight loss on serum leptin concentration in overweight, treated-hypertensive subjects , 2004, Journal of hypertension.
[46] A. Gressner,et al. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. , 2004, Clinical chemistry.
[47] Nader Rifai,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[48] V. Somers,et al. Independent Association Between Plasma Leptin and C-Reactive Protein in Healthy Humans , 2004, Circulation.
[49] Y. Shimada,et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease , 2004, Heart.
[50] C. Serhan,et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. , 2004, Prostaglandins & other lipid mediators.
[51] Yi-Hao Yu,et al. Chronological changes in metabolism and functions of cultured adipocytes: a hypothesis for cell aging in mature adipocytes. , 2004, American journal of physiology. Endocrinology and metabolism.
[52] Philippe Froguel,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.
[53] N. Espat,et al. Inhibition of activator protein-1 transcription factor activation by omega-3 fatty acid modulation of mitogen-activated protein kinase signaling kinases. , 2003, JPEN. Journal of parenteral and enteral nutrition.
[54] M. Buemi,et al. Leptin-dependent platelet aggregation in healthy, overweight and obese subjects , 2003, International Journal of Obesity.
[55] J. Shaw,et al. Overweight and obesity in Australia: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab) , 2003, The Medical journal of Australia.
[56] Alessandro Pontillo,et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.
[57] C. Mantzoros,et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. , 2003, The Journal of clinical endocrinology and metabolism.
[58] C. Mantzoros,et al. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. , 2003, The Journal of clinical endocrinology and metabolism.
[59] A. Simopoulos. Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases , 2002, Journal of the American College of Nutrition.
[60] H. Lodish,et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[61] K. Borch-Johnsen,et al. Diabetes and impaired glucose tolerance among the inuit population of Greenland. , 2002, Diabetes care.
[62] G. Slama,et al. Dietary (n-3) polyunsaturated fatty acids up-regulate plasma leptin in insulin-resistant rats. , 2002, The Journal of nutrition.
[63] V. Somers,et al. Fish-Rich Diet, Leptin, and Body Mass , 2002, Circulation.
[64] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[65] E. Jéquier. Leptin Signaling, Adiposity, and Energy Balance , 2002, Annals of the New York Academy of Sciences.
[66] D. Loskutoff,et al. The Prothrombotic Effects of Leptin , 2001 .
[67] Y. Terauchi,et al. The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance* , 2001, The Journal of Biological Chemistry.
[68] M. Matsuda,et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.
[69] L S Geiss,et al. Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997: an increasing burden. , 2000, Diabetes care.
[70] J W Erdman,et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. , 2000, Stroke.
[71] F. Valagussa,et al. The results of the GISSI-Prevenzione trial in the general framework of secondary prevention. , 2000, European heart journal.
[72] K. Iida,et al. Stimulation by eicosapentaenoic acids of leptin mRNA expression and its secretion in mouse 3T3-L1 adipocytes in vitro. , 2000, Biochemical and biophysical research communications.
[73] G. Watts,et al. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. , 1999, The American journal of clinical nutrition.
[74] A. Simopoulos,et al. Essential fatty acids in health and chronic disease. , 1999, The American journal of clinical nutrition.
[75] C. Boozer,et al. The leptin-fat ratio is constant, and leptin may be part of two feedback mechanisms for maintaining the body fat set point in non-obese male Fischer 344 rats. , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[76] S. Helton,et al. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. , 1999, The Journal of surgical research.
[77] S. Coppack,et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[78] A. Ruello,et al. Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects , 1999, International Journal of Obesity.
[79] J. M. Beals,et al. Human obesity protein, leptin , 1998 .
[80] J. Halaas,et al. Leptin and the regulation of body weight in mammals , 1998, Nature.
[81] C. Drevon,et al. Under- and overreporting of energy intake related to weight status and lifestyle in a nationwide sample. , 1998, The American journal of clinical nutrition.
[82] K. Houseknecht,et al. The biology of leptin: a review. , 1998, Journal of animal science.
[83] T. Kirchgessner,et al. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. , 1997, The Journal of clinical investigation.
[84] J. Peters,et al. Polyunsaturated Fatty Acid Suppression of Hepatic Fatty Acid Synthase and S14 Gene Expression Does Not Require Peroxisome Proliferator-activated Receptor α* , 1997, The Journal of Biological Chemistry.
[85] J. Flier,et al. Leptin Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Messenger Ribonucleic Acid in Neurons of the Hypothalamic Paraventricular Nucleus. , 1997, Endocrinology.
[86] J. M. Beals,et al. Crystal structure of the obese protein Ieptin-E100 , 1997, Nature.
[87] W. Harris,et al. n-3 fatty acids and serum lipoproteins: animal studies. , 1997, The American journal of clinical nutrition.
[88] Keiji Wakabayashi,et al. Suppression of nitric oxide production in lipopolysaccharide-stimulated macrophage cells by omega 3 polyunsaturated fatty acids. , 1997, Japanese journal of cancer research : Gann.
[89] R. Steiner,et al. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. , 1997, The Journal of clinical endocrinology and metabolism.
[90] R. Miller,et al. Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils , 1996, The Journal of experimental medicine.
[91] R. Considine,et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.
[92] S. Endres,et al. n-3 polyunsaturated fatty acids and human cytokine synthesis. , 1996, Current opinion in lipidology.
[93] B. Lowell,et al. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action , 1995, Nature Medicine.
[94] J. Stengård,et al. Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study , 1995, Diabetes Care.
[95] R. Simsolo,et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.
[96] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[97] A. Adler,et al. Lower Prevalence of Impaired Glucose Tolerance and Diabetes Associated With Daily Seal Oil or Salmon Consumption among Alaska Natives , 1994, Diabetes Care.
[98] Thl. DOES FISH OIL LOWER BLOOD PRESSURE , 1993 .
[99] P. Whelton,et al. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. , 1993, Archives of internal medicine.
[100] Y. Nikitin,et al. Prevalence of diagnosed diabetes in circumpolar indigenous populations. , 1992, International journal of epidemiology.
[101] B. Goldin,et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. , 1991, The Journal of nutrition.
[102] R. DiGiacomo,et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. , 1990, Arthritis and rheumatism.
[103] P. Weber,et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. , 1989, The New England journal of medicine.
[104] R L Weinsier,et al. The effects of high and low energy density diets on satiety, energy intake, and eating time of obese and nonobese subjects. , 1983, The American journal of clinical nutrition.
[105] E. Scott,et al. Diabetes mellitus in Eskimos after a decade. , 1973, JAMA.
[106] M. Danhof. hiGhly Active AntiretrovirAl therApy in children , 2013 .
[107] E. Schmidt,et al. Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects. , 2012, Nutrition research.
[108] M. Wolters,et al. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. , 2009, Atherosclerosis.
[109] C. Ruxton,et al. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. , 2007, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[110] J. Ren. Leptin and hyperleptinemia – from friend to foe for cardiovascular function , 2004 .
[111] E. Schmidt. Marine n-3 fatty acids and thrombosis. , 2003, Thrombosis research.
[112] M. Matoulek,et al. Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptors levels. , 2003, Physiological research.
[113] Y. Terauchi,et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. , 2001, The Journal of biological chemistry.
[114] W. Buurman,et al. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals , 2001, International Journal of Obesity.
[115] D. Loskutoff,et al. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. , 2001, Annals of the New York Academy of Sciences.
[116] A. Barnett,et al. Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. , 2000, Molecular and cellular endocrinology.
[117] J. Flier,et al. Distinct Physiologic and Neuronal Responses to Decreased Leptin and Mild Hyperleptinemia , 1999 .
[118] M. Lane,et al. Leptin regulates proinflammatory immune responses. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[119] W. Harris,et al. n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.
[120] F. Thibault,et al. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. , 1997, Advances in experimental medicine and biology.
[121] J. Flier,et al. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. , 1997, Endocrinology.
[122] E. Jéquier. [Obesity. Impairment of energy intake or of energy expenditure]. , 1995, Annales d'endocrinologie.
[123] B. Holub. Omega-3 fatty acids in cardiovascular care , 2022 .